Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Requirement for Fc effector function is overcome by binding potency for broadly reactive anti-alphavirus antibodiesVictoria Callahan, Matthew S Sutton, Christina L Gardner, et al.
Science Translational Medicine|August 20, 2025
High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodiesVictoria Callahan, Matthew S Sutton, Christina L Gardner, et al.
Methods (San Diego, Calif.)|October 9, 2025
HI-CeFSpot: High-throughput Immune Cell FluoroSpot assayYogita Jethmalani, Matthew S Sutton, Robin Carroll, et al.
Science Advances|January 1, 2025
High-dose intravenous BCG vaccination induces enhanced immune signaling in the airwaysJoshua M Peters, Edward B Irvine, Mohau S Makatsa, et al.
Plos Pathogens|January 5, 2017
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization FingerprintingNicole A Doria-Rose, Han R Altae-Tran, Ryan S Roark, et al.
Cell|June 9, 2023
Vaccine elicitation and structural basis for antibody protection against alphavirusesMatthew S Sutton, Sergei Pletnev, Victoria Callahan, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
CD4 T cells and CD8α+ lymphocytes are necessary for intravenous BCG-induced protection against tuberculosis in macaquesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
The Journal of Experimental Medicine|February 6, 2025
Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytesAndrew W Simonson, Joseph J Zeppa, Allison N Bucsan, et al.
Journal of Virology|October 16, 2015
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional PotencyNicole A Doria-Rose, Jinal N Bhiman, Ryan S Roark, et al.
Pageof 2